Management of intracranial aneurysms associated with arteriovenous malformations

Bruno C. Flores, Daniel R. Klinger, Kim L. Rickert, Samuel L. Barnett, Babu G. Welch, Jonathan A. White, H. Hunt Batjer, Duke S. Samson

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Intracranial or brain arteriovenous malformations (BAVMs) are some of the most interesting and challenging lesions treated by the cerebrovascular neurosurgeon. It is generally believed that the combination of BAVMs and intracranial aneurysms (IAs) is associated with higher hemorrhage rates at presentation and higher rehemorrhage rates and thus with a more aggressive course and natural history. There is wide variation in the literature on the prevalence of BAVM-associated aneurysms (range 2.7%-58%), with 10%-20% being most often cited in the largest case series. The risk of intracranial hemorrhage in patients with unruptured BAVMs and coexisting IAs has been reported to be 7% annually, compared with 2%-4% annually for those with BAVM alone. Several different classification systems have been applied in an attempt to better understand the natural history of this combination of lesions and implications for treatment. Independent of the classification used, it is clear that a few subtypes of aneurysms have a direct hemodynamic correlation with the BAVM itself. This is exemplified by the fact that the presence of a distal flowrelated or an intranidal aneurysm appears to be associated with an increased hemorrhage risk, when compared with an aneurysm located on a vessel with no direct supply to the BAVM nidus. Debate still exists regarding the etiology of the association between those two vascular lesions, the subsequent implications for patients' risk of hemorrhagic stroke, and finally the determination of which patients warrant treatment and when. The ultimate goals of the treatment of a BAVM associated with an IA are to prevent hemorrhage, avoid stepwise neurological deterioration, and eliminate the mortality risk associated with recurrent hemorrhagic events. The treatment is only justifiable if the risks associated with an intervention are lower than or equivalent to the long-term risks of disability or mortality caused by the lesion itself. When faced with this difficult decision, a few questions need to be answered by the treating neurosurgeon: What is the mode of presentation? What is the symptomatic lesion? Which one of the lesions bled? What is the relationship between the BAVM and IA? Is it possible to safely treat both BAVM and IA? The objective of this review is to discuss the demographics, natural history, classification, and strategies for management of BAVMs associated with IAs.

Original languageEnglish (US)
Article numberArticle E11
JournalNeurosurgical Focus
Volume37
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Arteriovenous Malformations
Intracranial Aneurysm
Brain
Intracranial Arteriovenous Malformations
Aneurysm
Arteriovenous Fistula
Natural History
Hemorrhage
Mortality
Intracranial Hemorrhages
Therapeutics
Blood Vessels
Hemodynamics
Stroke
Demography

Keywords

  • Brain arteriovenous malformation
  • Flow-related aneurysm
  • Intranidal aneurysm
  • Management strategies
  • Review

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Management of intracranial aneurysms associated with arteriovenous malformations. / Flores, Bruno C.; Klinger, Daniel R.; Rickert, Kim L.; Barnett, Samuel L.; Welch, Babu G.; White, Jonathan A.; Batjer, H. Hunt; Samson, Duke S.

In: Neurosurgical Focus, Vol. 37, No. 3, Article E11, 2014.

Research output: Contribution to journalArticle

@article{1898d227990a4fe8b22776e7351283af,
title = "Management of intracranial aneurysms associated with arteriovenous malformations",
abstract = "Intracranial or brain arteriovenous malformations (BAVMs) are some of the most interesting and challenging lesions treated by the cerebrovascular neurosurgeon. It is generally believed that the combination of BAVMs and intracranial aneurysms (IAs) is associated with higher hemorrhage rates at presentation and higher rehemorrhage rates and thus with a more aggressive course and natural history. There is wide variation in the literature on the prevalence of BAVM-associated aneurysms (range 2.7{\%}-58{\%}), with 10{\%}-20{\%} being most often cited in the largest case series. The risk of intracranial hemorrhage in patients with unruptured BAVMs and coexisting IAs has been reported to be 7{\%} annually, compared with 2{\%}-4{\%} annually for those with BAVM alone. Several different classification systems have been applied in an attempt to better understand the natural history of this combination of lesions and implications for treatment. Independent of the classification used, it is clear that a few subtypes of aneurysms have a direct hemodynamic correlation with the BAVM itself. This is exemplified by the fact that the presence of a distal flowrelated or an intranidal aneurysm appears to be associated with an increased hemorrhage risk, when compared with an aneurysm located on a vessel with no direct supply to the BAVM nidus. Debate still exists regarding the etiology of the association between those two vascular lesions, the subsequent implications for patients' risk of hemorrhagic stroke, and finally the determination of which patients warrant treatment and when. The ultimate goals of the treatment of a BAVM associated with an IA are to prevent hemorrhage, avoid stepwise neurological deterioration, and eliminate the mortality risk associated with recurrent hemorrhagic events. The treatment is only justifiable if the risks associated with an intervention are lower than or equivalent to the long-term risks of disability or mortality caused by the lesion itself. When faced with this difficult decision, a few questions need to be answered by the treating neurosurgeon: What is the mode of presentation? What is the symptomatic lesion? Which one of the lesions bled? What is the relationship between the BAVM and IA? Is it possible to safely treat both BAVM and IA? The objective of this review is to discuss the demographics, natural history, classification, and strategies for management of BAVMs associated with IAs.",
keywords = "Brain arteriovenous malformation, Flow-related aneurysm, Intranidal aneurysm, Management strategies, Review",
author = "Flores, {Bruno C.} and Klinger, {Daniel R.} and Rickert, {Kim L.} and Barnett, {Samuel L.} and Welch, {Babu G.} and White, {Jonathan A.} and Batjer, {H. Hunt} and Samson, {Duke S.}",
year = "2014",
doi = "10.3171/2014.6.FOCUS14165",
language = "English (US)",
volume = "37",
journal = "Neurosurgical Focus",
issn = "1092-0684",
publisher = "American Association of Neurological Surgeons",
number = "3",

}

TY - JOUR

T1 - Management of intracranial aneurysms associated with arteriovenous malformations

AU - Flores, Bruno C.

AU - Klinger, Daniel R.

AU - Rickert, Kim L.

AU - Barnett, Samuel L.

AU - Welch, Babu G.

AU - White, Jonathan A.

AU - Batjer, H. Hunt

AU - Samson, Duke S.

PY - 2014

Y1 - 2014

N2 - Intracranial or brain arteriovenous malformations (BAVMs) are some of the most interesting and challenging lesions treated by the cerebrovascular neurosurgeon. It is generally believed that the combination of BAVMs and intracranial aneurysms (IAs) is associated with higher hemorrhage rates at presentation and higher rehemorrhage rates and thus with a more aggressive course and natural history. There is wide variation in the literature on the prevalence of BAVM-associated aneurysms (range 2.7%-58%), with 10%-20% being most often cited in the largest case series. The risk of intracranial hemorrhage in patients with unruptured BAVMs and coexisting IAs has been reported to be 7% annually, compared with 2%-4% annually for those with BAVM alone. Several different classification systems have been applied in an attempt to better understand the natural history of this combination of lesions and implications for treatment. Independent of the classification used, it is clear that a few subtypes of aneurysms have a direct hemodynamic correlation with the BAVM itself. This is exemplified by the fact that the presence of a distal flowrelated or an intranidal aneurysm appears to be associated with an increased hemorrhage risk, when compared with an aneurysm located on a vessel with no direct supply to the BAVM nidus. Debate still exists regarding the etiology of the association between those two vascular lesions, the subsequent implications for patients' risk of hemorrhagic stroke, and finally the determination of which patients warrant treatment and when. The ultimate goals of the treatment of a BAVM associated with an IA are to prevent hemorrhage, avoid stepwise neurological deterioration, and eliminate the mortality risk associated with recurrent hemorrhagic events. The treatment is only justifiable if the risks associated with an intervention are lower than or equivalent to the long-term risks of disability or mortality caused by the lesion itself. When faced with this difficult decision, a few questions need to be answered by the treating neurosurgeon: What is the mode of presentation? What is the symptomatic lesion? Which one of the lesions bled? What is the relationship between the BAVM and IA? Is it possible to safely treat both BAVM and IA? The objective of this review is to discuss the demographics, natural history, classification, and strategies for management of BAVMs associated with IAs.

AB - Intracranial or brain arteriovenous malformations (BAVMs) are some of the most interesting and challenging lesions treated by the cerebrovascular neurosurgeon. It is generally believed that the combination of BAVMs and intracranial aneurysms (IAs) is associated with higher hemorrhage rates at presentation and higher rehemorrhage rates and thus with a more aggressive course and natural history. There is wide variation in the literature on the prevalence of BAVM-associated aneurysms (range 2.7%-58%), with 10%-20% being most often cited in the largest case series. The risk of intracranial hemorrhage in patients with unruptured BAVMs and coexisting IAs has been reported to be 7% annually, compared with 2%-4% annually for those with BAVM alone. Several different classification systems have been applied in an attempt to better understand the natural history of this combination of lesions and implications for treatment. Independent of the classification used, it is clear that a few subtypes of aneurysms have a direct hemodynamic correlation with the BAVM itself. This is exemplified by the fact that the presence of a distal flowrelated or an intranidal aneurysm appears to be associated with an increased hemorrhage risk, when compared with an aneurysm located on a vessel with no direct supply to the BAVM nidus. Debate still exists regarding the etiology of the association between those two vascular lesions, the subsequent implications for patients' risk of hemorrhagic stroke, and finally the determination of which patients warrant treatment and when. The ultimate goals of the treatment of a BAVM associated with an IA are to prevent hemorrhage, avoid stepwise neurological deterioration, and eliminate the mortality risk associated with recurrent hemorrhagic events. The treatment is only justifiable if the risks associated with an intervention are lower than or equivalent to the long-term risks of disability or mortality caused by the lesion itself. When faced with this difficult decision, a few questions need to be answered by the treating neurosurgeon: What is the mode of presentation? What is the symptomatic lesion? Which one of the lesions bled? What is the relationship between the BAVM and IA? Is it possible to safely treat both BAVM and IA? The objective of this review is to discuss the demographics, natural history, classification, and strategies for management of BAVMs associated with IAs.

KW - Brain arteriovenous malformation

KW - Flow-related aneurysm

KW - Intranidal aneurysm

KW - Management strategies

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=84907330863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907330863&partnerID=8YFLogxK

U2 - 10.3171/2014.6.FOCUS14165

DO - 10.3171/2014.6.FOCUS14165

M3 - Article

C2 - 25175430

AN - SCOPUS:84907330863

VL - 37

JO - Neurosurgical Focus

JF - Neurosurgical Focus

SN - 1092-0684

IS - 3

M1 - Article E11

ER -